Key Breast Journal Articles - Adjuvant Chemo

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open label, phase III, randomised controlled trial
P Ellis, P Barrett-Lee, L Johnson, D Cameron, A Wardley, S O'Reilly, M Verrill, I SMith, J Yarnold, R Coleman, H Earl, P Canney, C Twelves, C Poole, D Bloomfield, P Hopwood, S Johnston, M Dowsett, J Bartlet, I Ellis, C Peckitt, E Hall, & JM Bliss
Lancet. May 16 2009; 373(9676):1681-92
Journal | Pubmed

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thürlimann, HJ Senn, & Panel Members
Ann Oncol. 2007; 18(7):1133-44
Journal | Pubmed

Her2 and Response to Paclitaxel in Node Positive Breast Cancer
DF Hayes, AD Thor, LG Dressler, D Weaver, S Edgerton, D Cowan, G Broadwater, LJ Goldstein, S Martino, JN Ingle, IC Henderson, L Norton, EP Winer, CA Hudis, MJ Ellis, & DA Berry; for the Cancer and Leukemia Group B (CALGB) Investigators
NEJM. Oct 11 2007; 357(15):1496-506
Article review by Dr S Verma | ASCO Perspectives | Journal | Pubmed

Current Concepts: Local Therapy and Survival in Breast Cancer
RS Punglia, M Morrow, EP Winer, & JR Harris
NEJM. Jun 7 2007; 356(23):2399-405
Journal | Pubmed

Meta-analysis of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview
M Clarke
Ann Oncol. (Supplement 10) 2006; x59-x62
Journal

Sequential Adjuvant Epirubicin-Based and Docetaxel Chemotherapy for Node-Positive Breast Cancer Patients: The FNCLCC PACS 01 Trial
H Roché, P Fumoleau, M Spielmann, JL Canon, T Delozier, D Serin, M Symann, P Kerbrat, P Soulié, F Eichler, P Viens, A Monnier, A Vindevoghel, M Campone, MJ Goudier, J Bonneterre, JM Ferrero, AL Martin, J Genève, & B Asselain
JCO. Dec 20 2006; 24(36):5664-71
Journal | Pubmed

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
S Paik, G Tang, S Shak, C Kim, J Baker, W Kim, M Cronin, FL Baehner, D Watson, J Bryant, JP Costantino, CE Geyer Jr, DL Wickerham, & N Wolmark
JCO. Aug 10 2006; 24(23):3726-34
Journal | Pubmed

HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
KI Pritchard, LE Shepherd, FP O'Malley, IL Andrulis, D Tu, VH Bramwell, & MN Levine; the National Cancer Institute of Canada Clinical Trials Group
NEJM. May 18 2006; 354(20):2103-11
Journal | Pubmed

Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer
DA Berry, C Cirrincione, IC Henderson, ML Citron, DR Budman, LJ Goldstein, S Martino, EA Perez, HB Muss, L Norton, C Hudis, & EP Winer
JAMA. Apr 12 2006; 295(14):1658-67
Journal | Pubmed

Adjuvant Therapy for Breast Cancer in Older Women
A Hurria
ASCO 2006 Educational Book
ASCO

Adjuvant Chemotherapy for Patients With Estrogen Receptor--Positive Breast Cancer
HJ Burstein, S Paik, PM Ravdin, & KS Albain
ASCO 2006 Educational Book.
Journal

Five year follow-up of INT C9741: dose-dense (DD) chemotherapy (CRx) is safe and effective, SABCS (2005)
C Hudis, M Citron, D Berry, C Cirrincione, W Gradishar, N Davidson, S Martino, R Livingston, J Ingle, E Perez, J Abrams, R Schilsky, M Ellis, H Muss, L Norton, & E Winer
SABCS (2005). Abstr. 41C
Pubmed

Selection of Adjuvant Chemotherapy for Treatment of Node-positive Breast Cancer
M Trudeau, F Charbonneau, K Gelmon, K Laing, J Latreille, J Mackey, D McLeod, K Pritchard, L Provencher, & S Verma
Lancet Oncol. Nov 2005; 6(11):886-98
Journal

Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With Node-Positive Breast Cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
MN Levine, KI Pritchard, VHC Bramwell, LE Shepherd, D Tu, & N Paul
JCO. Aug 1 2005; 23(22):5166-70
Journal | Pubmed

Adjuvant Docetaxel for Node-Positive Breast Cancer
M Martin, T Pienkowski, J Mackey, M Pawlicki, JP Guastalla, C Weaver, E Tomiak, T Al-Tweigeri, L Chap, E Juhos, R Guevin, A Howell, T Fornander, J Hainsworth, R Coleman, J Vinholes, M Modiano, T Pinter, SC Tang, B Colwell, C Prady, L Provencher, D Walde, A Rodriguez-Lescure, J Hugh, C Loret, M Rupin, S Blitz, P Jacobs, M Murawsky, A Riva, & C Vogel; the Breast Cancer International Research Group 001 Investigators
NEJM. Jun 2 2005; 352(22):2302-13
Journal | Pubmed

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet. May 14-20 2005; 365(9472):1687-717
Journal | PubMed

Adjuvant Chemotherapy in Older and Younger Women With Lymph Node–Positive Breast Cancer
HB Muss, S Woolf, D Berry, C Cirrincione, RB Weiss, D Budman, WC Wood, IC Henderson, C Hudis, E Winer, H Cohen, J Wheeler, & L Norton; for the Cancer and Leukemia Group B
JAMA. March 2 2005; 293(9):1073-81
Journal | Pubmed

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, MG Walker, D Watson, T Park, W Hiller, ER Fisher, DL Wickerham, J Bryant, & N Wolmark
NEJM. Dec 30 2004; 351(27):2817-26
Journal | Pubmed

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
ML Citron, DA Berry, C Cirrincione, C Hudis, EP Winer, WJ Gradishar, NE Davidson, S Martino, R Livingston, JN Ingle, EA Perez, J Carpenter, D Hurd, JF Holland, BL SMith, CI Sartor, EH Leung, J Abrams, RL Schilsky, HB Mss, & L Norton
J Clin Oncol. Apr 2003; 21(8):1431-9
Journal | Pubmed

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the international Breast Cancer Study Group (IBCSG) trial VI
O Pagani, A O’Neill, M Castiglione, RD Gelber, A Goldhirsch, CM Rudenstam, J Lindtner, J Collins, D Crivellari, A Coates, F Cavalli, B Thürlimann, E Simoncini, M Fey, K Price, & HJ Senn
Eur J Cancer. Apr 1998; 34(5):632-40
Journal | Pubmed

Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22
B Fisher, S Anderson, DL Wickerham, A DeCillis, N Dimitrov, E Mamounas, N Wolmark, R Pugh, JN Atkins, FJ Meyers, N Abramson, J Wolter, RS Bornstein, L Levy, EH Romond, V Caggiano, M Grimaldi, P Jochimsen, & P Deckers
JCO. May 1 1997; 15(5):1858-69
Journal | Pubmed

Back to Top